866-997-4948(US-Canada Toll Free)

XEPTAGEN SpA - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 38 Pages


XEPTAGEN SpA (XEPTAGEN) is a medical device company, based in Italy. The company discovers novel molecular markers to produce diagnostic kits for the early detection, monitoring, and screening of cancerous cells. It develops the products for the treatments of liver cancer, colorectal cancer, prostate cancer and squamous cell carcinomas. XEPTAGEN products are marketed under the brand name HEPA AB, HEPA IC, HEPA AFPIC, COLONIC, PROSTATEIC and SCCALISA. The company uses proprietary platform technology called Combinatorial Proteomic to discover specific tumor markers. It develops an optoelectronic biochip for the determination of tumor molecular markers. The company partners with Associazione ABO, Olivetti I-jet S.p.A, University of Bologna, University of Brescia, University of Padova, ICS-UNIDO and University of Pisa among others. XEPTAGEN is headquartered in Marghera, Veneto, Italy.

This report is a source for data, analysis and actionable intelligence on the XEPTAGEN SpA portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 4
List of Figures 5

Key Facts 6
XEPTAGEN SpA - Major Products and Services 7
XEPTAGEN SpA Pipeline Products by Equipment Type 8
XEPTAGEN SpA Pipeline Products by Development Stage 10
XEPTAGEN SpA Pipeline Products by Therapy Area 12
XEPTAGEN SpA Pipeline Products by Trial Phase 14
CA15.3 - IgM Kit 16
CA15.3 - IgM Kit Product Status 16
CA15.3 - IgM Kit Product Description 16
CA15.3 - IgM Kit Product Patent Details 16
CA19.9 - IgM Kit 17
CA19.9 - IgM Kit Product Status 17
CA19.9 - IgM Kit Product Description 17
CA19.9 - IgM Kit Product Patent Details 17
CEA - IgM Kit - Breast Cancer 19
CEA - IgM Kit - Breast Cancer Product Status 19
CEA - IgM Kit - Breast Cancer Product Description 19
compleXima CRC Biochip 20
compleXima CRC Biochip Product Status 20
compleXima CRC Biochip Product Description 20
compleXima HCC Biochip 21
compleXima HCC Biochip Product Status 21
compleXima HCC Biochip Product Description 21
compleXima Multi Marker Biochip 22
compleXima Multi Marker Biochip Product Status 22
compleXima Multi Marker Biochip Product Description 22
compleXima Multi Marker Biochip Product Patent Details 22
DCP-IgM Kit - Liver Cancer 23
DCP-IgM Kit - Liver Cancer Product Status 23
DCP-IgM Kit - Liver Cancer Product Description 23
DCP-IgM Kit - Liver Cancer Clinical Trial 23
DCP-IgM Kit - Liver Cancer Product Patent Details 25
GPC3-IgM Kit - Liver Cancer 26
GPC3-IgM Kit - Liver Cancer Product Status 26
GPC3-IgM Kit - Liver Cancer Product Description 26
GPC3-IgM Kit - Liver Cancer Product Patent Details 26
Osteopontin - IgM Kit - Liver Cancer 27
Osteopontin - IgM Kit - Liver Cancer Product Status 27
Osteopontin - IgM Kit - Liver Cancer Product Description 27
Osteopontin - IgM Kit - Liver Cancer Product Patent Details 27
SCCA - IgM Kit - Cervical Cancer 28
SCCA - IgM Kit - Cervical Cancer Product Status 28
SCCA - IgM Kit - Cervical Cancer Product Description 28
SCCA - IgM Kit - Esophageal Cancer 29
SCCA - IgM Kit - Esophageal Cancer Product Status 29
SCCA - IgM Kit - Esophageal Cancer Product Description 29
SCCA - IgM Kit - Esophageal Cancer Product Patent Details 29
SCCA - IgM Kit - Pulmonary Cancer 30
SCCA - IgM Kit - Pulmonary Cancer Product Status 30
SCCA - IgM Kit - Pulmonary Cancer Product Description 30
SCCA - IgM Kit - Pulmonary Cancer Product Patent Details 30
SCCA - IgM Kit Scleroderma 31
SCCA - IgM Kit Scleroderma Product Status 31
SCCA - IgM Kit Scleroderma Product Description 31
Survivin - IgM Kit - Liver Cancer 32
Survivin - IgM Kit - Liver Cancer Product Status 32
Survivin - IgM Kit - Liver Cancer Product Description 32
Survivin - IgM Kit - Liver Cancer Product Patent Details 32
VEGF - IgM Kit - Liver Cancer 33
VEGF - IgM Kit - Liver Cancer Product Status 33
VEGF - IgM Kit - Liver Cancer Product Description 33
VEGF - IgM Kit - Liver Cancer Product Patent Details 33
VEGF - IgM Kit - Pulmonary Cancer 34
VEGF - IgM Kit - Pulmonary Cancer Product Status 34
VEGF - IgM Kit - Pulmonary Cancer Product Description 34
VEGF - IgM Kit - Pulmonary Cancer Product Patent Details 34
XEPTAGEN SpA - Key Competitors 35
XEPTAGEN SpA - Key Employees 36
XEPTAGEN SpA - Locations And Subsidiaries 37
Head Office 37

Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Table


XEPTAGEN SpA, Key Facts 1
XEPTAGEN SpA Key Pipeline Products by Equipment Type 1
XEPTAGEN SpA Key Pipeline Products by Therapy Area 1
XEPTAGEN SpA Key Pipeline Products by Development Stage 1
XEPTAGEN SpA Key Pipeline Products by Trial Phase 1
XEPTAGEN SpA, Key Facts 6
XEPTAGEN SpA, Major Products and Services 7
XEPTAGEN SpA Number of Pipeline Products by Equipment Type 8
XEPTAGEN SpA Pipeline Products by Equipment Type 9
XEPTAGEN SpA Number of Pipeline Products by Development Stage 10
XEPTAGEN SpA Pipeline Products by Development Stage 11
XEPTAGEN SpA Number of Pipeline Products by Therapy Area 12
XEPTAGEN SpA Pipeline Products by Therapy Area 13
XEPTAGEN SpA Number of Pipeline Products by Trial Phase 14
XEPTAGEN SpA Pipeline Products by Trial Phase 15
CA15.3 - IgM Kit - Product Status 16
CA15.3 - IgM Kit - Product Description 16
CA15.3 - IgM Kit - Patent Details1 16
CA19.9 - IgM Kit - Product Status 17
CA19.9 - IgM Kit - Product Description 17
CA19.9 - IgM Kit - Patent Details1 17
CEA - IgM Kit - Breast Cancer - Product Status 19
CEA - IgM Kit - Breast Cancer - Product Description 19
compleXima CRC Biochip - Product Status 20
compleXima CRC Biochip - Product Description 20
compleXima HCC Biochip - Product Status 21
compleXima HCC Biochip - Product Description 21
compleXima Multi Marker Biochip - Product Status 22
compleXima Multi Marker Biochip - Product Description 22
compleXima Multi Marker Biochip - Patent Details1 22
DCP-IgM Kit - Liver Cancer - Product Status 23
DCP-IgM Kit - Liver Cancer - Product Description 23
DCP-IgM Kit - Liver Cancer - Evaluation of DCP-IgM markers as diagnostic tools for liver cancer 23
DCP-IgM Kit - Liver Cancer - Patent Details1 25
GPC3-IgM Kit - Liver Cancer - Product Status 26
GPC3-IgM Kit - Liver Cancer - Product Description 26
GPC3-IgM Kit - Liver Cancer - Patent Details1 26
Osteopontin - IgM Kit - Liver Cancer - Product Status 27
Osteopontin - IgM Kit - Liver Cancer - Product Description 27
Osteopontin - IgM Kit - Liver Cancer - Patent Details1 27
SCCA - IgM Kit - Cervical Cancer - Product Status 28
SCCA - IgM Kit - Cervical Cancer - Product Description 28
SCCA - IgM Kit - Esophageal Cancer - Product Status 29
SCCA - IgM Kit - Esophageal Cancer - Product Description 29
SCCA - IgM Kit - Esophageal Cancer - Patent Details1 29
SCCA - IgM Kit - Pulmonary Cancer - Product Status 30
SCCA - IgM Kit - Pulmonary Cancer - Product Description 30
SCCA - IgM Kit - Pulmonary Cancer - Patent Details1 30
SCCA - IgM Kit Scleroderma - Product Status 31
SCCA - IgM Kit Scleroderma - Product Description 31
Survivin - IgM Kit - Liver Cancer - Product Status 32
Survivin - IgM Kit - Liver Cancer - Product Description 32
Survivin - IgM Kit - Liver Cancer - Patent Details1 32
VEGF - IgM Kit - Liver Cancer - Product Status 33
VEGF - IgM Kit - Liver Cancer - Product Description 33
VEGF - IgM Kit - Liver Cancer - Patent Details1 33
VEGF - IgM Kit - Pulmonary Cancer - Product Status 34
VEGF - IgM Kit - Pulmonary Cancer - Product Description 34
VEGF - IgM Kit - Pulmonary Cancer - Patent Details1 34
XEPTAGEN SpA, Key Employees 36

List of Chart


XEPTAGEN SpA Pipeline Products by Equipment Type 8
XEPTAGEN SpA Pipeline Products by Development Stage 10
XEPTAGEN SpA Pipeline Products by Therapy Area 12
XEPTAGEN SpA Pipeline Products by Trial Phase 14

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *